These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 30413179)

  • 21. In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stem cell tropism to malignant gliomas using magnetic resonance imaging. Laboratory investigation.
    Wu X; Hu J; Zhou L; Mao Y; Yang B; Gao L; Xie R; Xu F; Zhang D; Liu J; Zhu J
    J Neurosurg; 2008 Feb; 108(2):320-9. PubMed ID: 18240929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens.
    Kelly JJ; Stechishin O; Chojnacki A; Lun X; Sun B; Senger DL; Forsyth P; Auer RN; Dunn JF; Cairncross JG; Parney IF; Weiss S
    Stem Cells; 2009 Aug; 27(8):1722-33. PubMed ID: 19544433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Adipose Tissue-Derived Mesenchymal Stem Cells Target Brain Tumor-Initiating Cells.
    Choi SA; Lee JY; Kwon SE; Wang KC; Phi JH; Choi JW; Jin X; Lim JY; Kim H; Kim SK
    PLoS One; 2015; 10(6):e0129292. PubMed ID: 26076490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo tracking of the tropism of mesenchymal stem cells to malignant gliomas using reporter gene-based MR imaging.
    Cao M; Mao J; Duan X; Lu L; Zhang F; Lin B; Chen M; Zheng C; Zhang X; Shen J
    Int J Cancer; 2018 Mar; 142(5):1033-1046. PubMed ID: 29047121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors.
    Bajetto A; Pattarozzi A; Corsaro A; Barbieri F; Daga A; Bosio A; Gatti M; Pisaturo V; Sirito R; Florio T
    Front Cell Neurosci; 2017; 11():312. PubMed ID: 29081734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies.
    Bajetto A; Thellung S; Dellacasagrande I; Pagano A; Barbieri F; Florio T
    Stem Cells Transl Med; 2020 Nov; 9(11):1310-1330. PubMed ID: 32543030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury.
    Ji JF; He BP; Dheen ST; Tay SS
    Stem Cells; 2004; 22(3):415-27. PubMed ID: 15153618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bmi1 marks intermediate precursors during differentiation of human brain tumor initiating cells.
    Venugopal C; Li N; Wang X; Manoranjan B; Hawkins C; Gunnarsson T; Hollenberg R; Klurfan P; Murty N; Kwiecien J; Farrokhyar F; Provias JP; Wynder C; Singh SK
    Stem Cell Res; 2012 Mar; 8(2):141-53. PubMed ID: 22265735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
    Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ
    Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a novel imaging agent using peptide-coated gold nanoparticles toward brain glioma stem cell marker CD133.
    Cho JH; Kim AR; Kim SH; Lee SJ; Chung H; Yoon MY
    Acta Biomater; 2017 Jan; 47():182-192. PubMed ID: 27721007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts.
    Pacioni S; D'Alessandris QG; Giannetti S; Morgante L; Coccè V; Bonomi A; Buccarelli M; Pascucci L; Alessandri G; Pessina A; Ricci-Vitiani L; Falchetti ML; Pallini R
    Stem Cell Res Ther; 2017 Mar; 8(1):53. PubMed ID: 28279193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI tracking of polyethylene glycol-coated superparamagnetic iron oxide-labelled placenta-derived mesenchymal stem cells toward glioblastoma stem-like cells in a mouse model.
    Hsu FT; Wei ZH; Hsuan YC; Lin W; Su YC; Liao CH; Hsieh CL
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S448-S459. PubMed ID: 30198338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component.
    Kahlert UD; Bender NO; Maciaczyk D; Bogiel T; Bar EE; Eberhart CG; Nikkhah G; Maciaczyk J
    Folia Neuropathol; 2012; 50(4):357-68. PubMed ID: 23319191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities.
    Ponte AL; Marais E; Gallay N; Langonné A; Delorme B; Hérault O; Charbord P; Domenech J
    Stem Cells; 2007 Jul; 25(7):1737-45. PubMed ID: 17395768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human mesenchymal stem cells exploit the immune response mediating chemokines to impact the phenotype of glioblastoma.
    Motaln H; Gruden K; Hren M; Schichor C; Primon M; Rotter A; Lah TT
    Cell Transplant; 2012; 21(7):1529-45. PubMed ID: 22554389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain tumor stem cells from an adenoid glioblastoma multiforme.
    Oka N; Soeda A; Noda S; Iwama T
    Neurol Med Chir (Tokyo); 2009 Apr; 49(4):146-50; discussion 150-1. PubMed ID: 19398857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurogenic and neuro-protective potential of a novel subpopulation of peripheral blood-derived CD133+ ABCG2+CXCR4+ mesenchymal stem cells: development of autologous cell-based therapeutics for traumatic brain injury.
    Nichols JE; Niles JA; DeWitt D; Prough D; Parsley M; Vega S; Cantu A; Lee E; Cortiella J
    Stem Cell Res Ther; 2013 Jan; 4(1):3. PubMed ID: 23290300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD133 is essential for glioblastoma stem cell maintenance.
    Brescia P; Ortensi B; Fornasari L; Levi D; Broggi G; Pelicci G
    Stem Cells; 2013 May; 31(5):857-69. PubMed ID: 23307586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific chemotaxis of magnetically labeled mesenchymal stem cells: implications for MRI of glioma.
    Bennewitz MF; Tang KS; Markakis EA; Shapiro EM
    Mol Imaging Biol; 2012 Dec; 14(6):676-87. PubMed ID: 22418788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of CD133 Targeting Multi-Drug Polymer Micellar Nanoparticles for Glioblastoma - In Vitro Evaluation in Glioblastoma Stem Cells.
    Smiley SB; Yun Y; Ayyagari P; Shannon HE; Pollok KE; Vannier MW; Das SK; Veronesi MC
    Pharm Res; 2021 Jun; 38(6):1067-1079. PubMed ID: 34100216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.